Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
Institut Bergonié
Hutchmed
Elevation Oncology
Intensity Therapeutics, Inc.
Sarcoma Oncology Research Center, LLC
National Cancer Institute (NCI)
Stanford University
BeiGene
National Cancer Institute (NCI)
TopAlliance Biosciences
Mundipharma Research Limited
Rain Oncology Inc
NantCell, Inc.
Pfizer
Children's Oncology Group
pharmaand GmbH
Hoffmann-La Roche
City of Hope Medical Center
Nektar Therapeutics
Ludwig Institute for Cancer Research
Ludwig Institute for Cancer Research
Novartis
National Institutes of Health Clinical Center (CC)
Novartis
Amgen
Asan Medical Center
Mayo Clinic
Sarcoma Alliance for Research through Collaboration
National Cancer Institute (NCI)
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
University of South Florida
National Cancer Institute (NCI)
INSYS Therapeutics Inc
Pfizer
H. Lee Moffitt Cancer Center and Research Institute